| CPC A61K 31/05 (2013.01) [A61K 8/042 (2013.01); A61K 8/347 (2013.01); A61K 8/9789 (2017.08); A61K 9/06 (2013.01); A61K 31/015 (2013.01); A61K 36/53 (2013.01); A61K 36/61 (2013.01); A61P 17/10 (2018.01); A61Q 19/00 (2013.01)] | 10 Claims |
|
1. A topical cannabinoid homogenous gel emulsion composition comprising
a cannabinoid at 0.1-10% (w/w),
an antioxidant at 0.01-5% (w/w),
an anti-microbial agent at 0.01-2% (w/w),
an anti-inflammatory agent at 0.01-5% (w/w) and
a skin conditioning agent at 0.01-5% (w/w),
wherein the topical cannabinoid homogenous gel emulsion composition comprises less than 20% (w/w) of simple polyol,
wherein the cannabinoid is cannabidiol (CBD),
wherein the anti-inflammatory agent is beta-caryophyllene, and
wherein the topical cannabinoid homogenous gel emulsion composition further comprises a humectant at 1-10% (w/w),
a thickening agent at 0.01-10% (w/w),
a gel-forming agent at 0.1-5% (w/w),
a preservative at 0.1-3% (w/w),
an emollient at 1-3% (w/w),
a non-ionic surfactant at 1-15% (w/w),
a penetration enhancer at 1-5% (w/w),
a fragrance agent at 0.01-2% (w/w),
a pH adjusting agent in a quantity sufficient for the topical cannabinoid homogenous gel emulsion composition to maintain pH 5-7, and
water to make up 100% by weight,
wherein the gel-forming agent is carbomer,
wherein the emollient is isopropyl myristate, and
wherein the penetration enhancer is diethylene glycol monoethyl ether.
|